中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
上海药物研究所 [56]
采集方式
OAI收割 [56]
内容类型
期刊论文 [55]
会议论文 [1]
发表日期
2023 [6]
2022 [9]
2021 [1]
2020 [3]
2019 [5]
2018 [5]
更多
学科主题
筛选
浏览/检索结果:
共56条,第1-10条
帮助
限定条件
专题:上海药物研究所
第一署名单位
第一作者单位
通讯作者单位
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
提交时间升序
提交时间降序
发表日期升序
发表日期降序
题名升序
题名降序
作者升序
作者降序
A compounds annotation strategy using targeted molecular networking for offline two-dimensional liquid chromatography-mass spectrometry analysis: Yupingfeng as a case study
期刊论文
OAI收割
JOURNAL OF CHROMATOGRAPHY A, 2023, 卷号: 1702, 页码: 13
作者:
Zhu, Haodong
;
He, Liangliang
;
Wu, Wenyong
;
Duan, Huifang
;
Chen, Jiali
  |  
收藏
  |  
浏览/下载:17/0
  |  
提交时间:2023/10/17
Compounds visual annotation
MS2-similarity adjacency matrix
Targeted molecular networking
Offline two-dimensional liquid
chromatography mass spectrometry systems
Yupingfeng
Investigation of targets and anticancer mechanisms of covalently acting natural products by functional proteomics
期刊论文
OAI收割
ACTA PHARMACOLOGICA SINICA, 2023, 卷号: 44, 期号: 8, 页码: 1701-1711
作者:
Zhao, Wen-si
;
Chen, Kai-feng
;
Liu, Man
;
Jia, Xing-long
;
Huang, Yu-qi
  |  
收藏
  |  
浏览/下载:1/0
  |  
提交时间:2024/03/27
natural products
proteomics
ABPP
eriocalyxin B
parthenolide
Pharmaco-proteogenomic characterization of liver cancer organoids for precision oncology
期刊论文
OAI收割
SCIENCE TRANSLATIONAL MEDICINE, 2023, 卷号: 15, 期号: 706, 页码: 15
作者:
Ji, Shuyi
;
Feng, Li
;
Fu, Zile
;
Wu, Gaohua
;
Wu, Yingcheng
  |  
收藏
  |  
浏览/下载:15/0
  |  
提交时间:2023/10/17
Proteomics of adjacent-to-tumor samples uncovers clinically relevant biological events in hepatocellular carcinoma
期刊论文
OAI收割
NATIONAL SCIENCE REVIEW, 2023, 卷号: 10, 期号: 8, 页码: 17
作者:
Zhu, Hongwen
;
Lin, Youpei
;
Lu, Dayun
;
Wang, Shisheng
;
Liu, Yuejia
  |  
收藏
  |  
浏览/下载:20/0
  |  
提交时间:2023/10/17
proteomics
hepatocellular carcinoma
normal tissue adjacent to tumor
heterogeneity
Unraveling the catalytic mechanism of SARS-CoV-2 papain-like protease with allosteric modulation of C270 mutation using multiscale computational approaches
期刊论文
OAI收割
CHEMICAL SCIENCE, 2023, 卷号: 14, 期号: 18, 页码: 4681-4696
作者:
Shao, Qiang
;
Xiong, Muya
;
Li, Jiameng
;
Hu, Hangchen
;
Su, Haixia
  |  
收藏
  |  
浏览/下载:0/0
  |  
提交时间:2024/03/27
Online Alkaline-pH Reverse Phase Nanoelectrospray-Tandem Mass Spectrometry Complements Conventional Low-pH Method for Global Proteomic Analysis
期刊论文
OAI收割
JOURNAL OF PROTEOME RESEARCH, 2023, 卷号: 22, 期号: 5, 页码: 1446-1454
作者:
Gao, Jing
;
Wang, Yuqiu
;
Zhang, Shu
;
Yang, Zhicheng
;
Zhu, Hongwen
  |  
收藏
  |  
浏览/下载:1/0
  |  
提交时间:2024/03/27
online alkaline-pH reverse phase
mass spectrometry
proteomics
amino acid variant
Identification of Cysteine 270 as a Novel Site for Allosteric Modulators of SARS-CoV-2 Papain-Like Protease
期刊论文
OAI收割
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2022, 页码: 10
作者:
Hu, Hangchen
;
Wang, Qian
;
Su, Haixia
;
Shao, Qiang
;
Zhao, Wenfeng
  |  
收藏
  |  
浏览/下载:11/0
  |  
提交时间:2023/04/10
Allosteric Modulator
Cysteine 270
Drug Design
Papain-Like Protease
SARS-CoV-2
ARID1A loss induces polymorphonuclear myeloid-derived suppressor cell chemotaxis and promotes prostate cancer progression
期刊论文
OAI收割
NATURE COMMUNICATIONS, 2022, 卷号: 13, 期号: 1, 页码: 20
作者:
Li, Ni
;
Liu, Qiuli
;
Han, Ying
;
Pei, Siyu
;
Cheng, Bisheng
  |  
收藏
  |  
浏览/下载:20/0
  |  
提交时间:2023/04/10
Blockage of PPAR gamma T166 phosphorylation enhances the inducibility of beige adipocytes and improves metabolic dysfunctions
期刊论文
OAI收割
CELL DEATH AND DIFFERENTIATION, 2022, 页码: 13
作者:
Yang, Nanfei
;
Wang, Yuxin
;
Tian, Qiang
;
Wang, Qiuping
;
Lu, Yan
  |  
收藏
  |  
浏览/下载:23/0
  |  
提交时间:2022/12/13
Multimodule characterization of immune subgroups in intrahepatic cholangiocarcinoma reveals distinct therapeutic vulnerabilities
期刊论文
OAI收割
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 卷号: 10, 期号: 7, 页码: 14
作者:
Lin, Jian
;
Dai, Yuting
;
Sang, Chen
;
Song, Guohe
;
Xiang, Bin
  |  
收藏
  |  
浏览/下载:35/0
  |  
提交时间:2022/08/30
tumor microenvironment
cytotoxicity
immunologic
drug therapy
combination